The global at-home testing market is expected to enjoy a valuation of USD 7.1 billion in 2022, and further expand at a CAGR of 4.0% to reach a valuation of USD 10.5 billion by the end of the year 2032. According to a recent study by Future Market Insights, digital monitoring system products are leading the market with a share of about 46.7% in the year 2021, within the global at-home testing market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 7.1 billion |
| Market Value 2032 | USD 10.5 billion |
| CAGR 2022 to 2032 | 4.0% |
| Market Share of Top 5 Countries | 55.5% |
| Key Market Players | Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA., Everlywell, and LetsgetChecked. |
The at-home testing market has gained popularity recently due to the numerous new alternatives it has provided for patients. They aid in the continuous monitoring of health issues, such as blood sugar and cholesterol levels, as well as the diagnosis and treatment of new patients who test positive for specific indications.
With at-home testing kits being well accepted in the market, manufacturers have seized the opportunity to offer novel kits for the well-being of patients suffering from chronic disorders, as well as in the management of several ailments.
One of the primary reasons for the market's predicted opportunistic expansion is the flexibility it affords to the self-testing audience. The rising usage of opioids and drug abuse testing has opened up new opportunities in the pain management area.
With so many brands of at-home testing kits available in the market, the FDA has set up certain regulations, including a warning about not using pre-used test strips, on 21 June 2022. It has also set up a website enlisting all the approved home tests.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for at-home testing products was approximately 5.8% of the overall ~USD 118.5 billion of the global in-vitro diagnostics market in 2021.
The at-home testing industry has drawn a lot of attention since it offers a highly convenient way to conduct tests from the comfort of one's own home. Market players are taking advantage of this opportunity to expand their businesses and branch out into other areas
The at-home market is predicted to grow throughout the forecast period, because of the increase in business development tactics such as collaboration and acquisition by leading industry players.
For instance, Viatris Inc along with Atomo Diagnostics Limited collaborated with the globally renounced health agency Unit Aid, in the year of April 2021, to make HIV testing kits more accessible in developing countries.
Another promising reason for the lucrative growth of the market is the increasing popularity of self-testing kits among consumers . Pregnancy self-tests and blood glucose self-testing have gained so much popularity through extensive marketing that they have now become routine and useful for consumers.
To ensure the efficacy of norms, the entire regulatory landscape in the self-testing business is continually altering. In-vitro diagnostic medical devices (IVD) regulations for self-testing kits are in effect in the United States.
Owing to the aforementioned factors, the at-home testing market is expected to grow at a CAGR of 4.0% during the forecast period from 2022 to 2032.
The market is set to present an opportunistic outlook, due to technological developments in sample collection and manufacturers' efforts to develop easy-to-use disposable test kits.
These test kits use sweat, semen, and even hair samples for giving test results, which sometimes the consumer is not comfortable giving in public. At-home testing kits have made this more accessible for consumers. People can be tested easily for fertility checks and even drug abuse.
The growth will further be propelled by the adoption of self-testing policies encouraging the use of self-diagnostic kits. Developed countries are enacting self-testing policies and developing self-testing guidelines.
According to the WHO, around 41 countries have implemented HIV self-testing policies. Many countries have similar policies in place for Hepatitis B and C.
With the implementation of such government laws, the general population is encouraged to utilize self-diagnostic kits, creating significant chances for the at-home testing market to flourish.
Principal Consultant
Despite the fact that the at-home testing market includes multiple end-uses, certain challenges are expected to impede market expansion. The price increase for at-home testing kits will be a setback for this sector. Self-testing policies and recommendations are being developed in developed countries. As a result, the high pricing of testing kits will prevent the market from expanding.
Additionally, the projected expansion of the global at-home testing market is anticipated to be hampered by the rising number of product recalls of self-testing kits by regulatory bodies like the USA FDA. There are multiple pieces of evidence of such recalls in the market.
These variables in total propose an adverse consequence on the formative development of the at-home testing market.
The USA dominates the North American region with a total market share of about 91.6 % in 2021 and is expected to continue the same through the forecast period.
This is because the USA market is highly fragmented with many new market players trying to promote their products, launch multiple innovative products, high prevalence of certain chronic and infectious diseases, and high awareness among consumers. The USA Federal government has also introduced a lot of schemes and awareness programs for the higher adoption of self-test kits and to get tested.
The rate of obese people living in the USA is also high, and high diabetic awareness has increased the adoption of continuous blood glucose monitors.
China is expected to display growth at a CAGR of 5.2% in the East Asia market over the forecast period.
The market for self-testing devices in China is increasing. Medical chemistry, immunoassay, coagulation, hematology, and microbiology are all highly sought-after fields. Another indicator of potential opportunities in China is the employment of in-house manufactured devices.
Because the country's economy is intricately linked to its healthcare system, the market is expected to grow in the future years. The Chinese government's expanding initiatives to promote the healthcare sector, which is another factor fuelling demand for self-testing kits.
The United Kingdom holds the largest market share in Europe at-home testing market in 2021 generating revenue of close to USD 386.2 million and is expected to grow with a CAGR of 2.2% during the forecasted period.
People's regular habit of visiting clinic have been replaced with the awareness of self-test kits in the market. Self-testing kits are readily accessible at pharmacies, and obtaining them has never been simpler. Numerous healthcare organizations are entering this market since they quickly produce self-test kits.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Digital monitoring systems held a market share of around 46.7% in the global market in 2021, and the segment is expected to grow with a CAGR of 4.4% during the forecast period.
The ability of sensors to record precise data for predicted, planned, and emergency maintenance adds cost efficiencies to digital monitoring. Furthermore, they are easy to use as they have stronger compliance as all the medical data is automatically stored in the system. Hence, they have a greater preference, and the market is set to expand as a result.
Blood glucose testing has shown increased demand with a market share of 70.4% globally in 2021 and is expected to grow with a CAGR of 3.8% during the forecast period.
Blood glucose monitors are widely used for home tests as they provide a timely and dependable assessment of an individual's blood glucose concentrations in order to make appropriate food, exercise, and medication decisions. In addition, they are handy, can be used for a prolonged time, and help to keep sugar levels in check.
Blood is widely used as a sample for at-home testing kits as it evaluates the overall health, checks the function of specific organs such as the liver and kidneys, and screens for genetic diseases. The segment holds the largest market share with revenue of nearly USD 5.1 billion in the global market and is expected to grow with a CAGR of 3.8% in the forecast period.
Drug stores hold the highest market share value of 49.6% during the year 2021 globally.
This is because most drug stores and local pharmacies have multiple options for home test kits. They are easily accessible, and consumers can select from a wide range of products. The presence of established drug store chains and supermarket chains like Walmart have even increased the adoption rate. Such chains are engaging in collaborations with at-home testing kit manufacturers to promote their products.
The market is highly fragmented and there are many companies operating and launching new products in the market. Key Players such as Abbott Diagnostics, and Quest Direct (Quest Diagnostics), are adopting expansion of their business in the untapped markets and acquisition of smaller companies to promote their products.
In order to meet consumer demand and grow their customer base, other companies are also following their footsteps to do mergers and acquisitions, partnerships and collaborations, and new product launches.
The following are examples of key development strategies used by industry players in the at-home testing market:
Similarly, recent developments related to companies manufacturing at-home testing products, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | USD billion for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa. |
| Key Market Segments Covered | Product, Application, Sample, Distribution Channel, and Region |
| Key Companies Profiled | Becton, Dickinson, and Company; Abbott; ACCESS BIO; CELLTRION INC.; Siemens Healthcare GmbH; ACON Laboratories Inc.; ARKRAY, Inc; F. Hoffmann-La Roche Ltd.; OraSure, Technologies Inc.; Quest Diagnostics; Bionime Corporation; Btnx Inc.; iHealth Labs Inc.; InBios International, Inc. USA.; EverlyWell; LetsgetChecked. |
| Pricing | Available upon Request |
The global at-home testing market is estimated to be worth USD 7.1 billion in 2022 and is set to expand 1.5X over the next ten years.
The at-home testing market is expected to reach USD 10.5 billion by the end of 2032, with sales revenue expected to register 4.0% CAGR.
The expanding research and development of the at-home testing products, increased awareness about health and hygiene, HIV health awareness, immense advertising, and increasing number of infectious diseases, are the key trends being witnessed in this market.
The USA, Japan, China, The United Kingdom, and France are the top five countries and are expected to drive demand for the at-home testing kits market.
North America is one of the key markets for at-home testing, with the USA accounting for around 91.6% of the North American at-home testing market in the year 2021.
Demand for at-home testing in Europe is expected to register a growth of 4.1% CAGR over the next ten years.
The USA, China, and the United Kingdom are the key producers of at-home testing products.
Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA, Everlywell, and LetsgetChecked, are the key players within the market.
The Japan market held a share of about 43.8% in the East Asia at-home testing market in 2021.
Digital monitoring system is the major product segment in the global at-home testing market with a share of 46.7% in the year 2021.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Market Demand in Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD million) Analysis 2015 to 2021 and Forecast, 2022 to 2032 9. Global Market Analysis, By Product 9.1. Digital Monitoring Instruments 9.2. Cassettes 9.3. Midstreams 9.4. Strips 9.5. Cups 9.6. Dip Cards 9.7. Test Panels 9.8. Sample collection kits 9.9. Others 10. Global Market Analysis, By Application 10.1. Blood Glucose Testing 10.2. Pregnancy & Fertility Testing 10.3. Cancer Testing 10.4. Search and Rescue 10.5. STD/ STI Testing 10.5.1. Chlamydia and Gonorrhea 10.5.2. HIV Testing 10.6. Cholesterol Testing 10.7. Testosterone Testing 10.8. Drug of Abuse Testing 10.9. Thyroid Testing 10.10. Others 11. Global Market Analysis, By Sample 11.1. Urine 11.2. Blood 11.3. Saliva 11.4. Stool 11.5. Vaginal Swab 11.6. Semen 12. Global Market Analysis, By Distribution Channel 12.1. Drug Stores 12.2. Hospital Pharmacies 12.3. Online Channels 13. Global Market Analysis, By Region 13.1. North America 13.2. Latin America 13.3. Europe 13.4. South Asia 13.5. East Asia 13.6. Oceania 13.7. Middle East & Africa 14. North America Market Analysis 15. Latin America Market Analysis 16. Europe Market Analysis 17. East Asia Market Analysis 18. Oceania Market Analysis 19. Middle East and Africa Market Analysis 20. Market Structure Analysis 21. Competition Analysis 21.1. Abbott 21.2. Becton, Dickinson and Company 21.3. ACCESS BIO 21.4. CELLTRION INC. 21.5. Siemens Healthcare GmbH 21.6. ACON Laboratories Inc. 21.7. ARKRAY, Inc 21.8. F. Hoffmann-La Roche Ltd. 21.9. OraSure Technologies Inc. 21.10. Quest Diagnostics 21.11. Bionime Corporation 21.12. Btnx Inc. 21.13. iHealth Labs Inc. 21.14. InBios International, Inc. USA. 21.15. Everlywell 21.16. LetsgetChecked 22. Assumptions and Acronyms Used 23. Research Methodology
Healthcare
June 2023
REP-GB-6108
342 pages
Explore Healthcare Insights
View Reports
At-Home Testing Market
